Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022.
Snowden JA, Sánchez-Ortega I, Corbacioglu S, Basak GW, Chabannon C, de la Camara R, Dolstra H, Duarte RF, Glass B, Greco R, Lankester AC, Mohty M, Neven B, de Latour RP, Pedrazzoli P, Peric Z, Yakoub-Agha I, Sureda A, Kröger N; European Society for Blood and Marrow Transplantation (EBMT). Snowden JA, et al. Among authors: de la camara r, de latour rp. Bone Marrow Transplant. 2022 Aug;57(8):1217-1239. doi: 10.1038/s41409-022-01691-w. Epub 2022 May 19. Bone Marrow Transplant. 2022. PMID: 35589997 Free PMC article.
Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
Robin M, Porcher R, De Castro Araujo R, de Latour RP, Devergie A, Rocha V, Larghero J, Adès L, Ribaud P, Mary JY, Socié G. Robin M, et al. Among authors: de castro araujo r, de latour rp. Biol Blood Marrow Transplant. 2007 Nov;13(11):1304-12. doi: 10.1016/j.bbmt.2007.07.007. Epub 2007 Sep 7. Biol Blood Marrow Transplant. 2007. PMID: 17950917 Free article.
Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire.
Le Gouill S, Milpied N, Buzyn A, De Latour RP, Vernant JP, Mohty M, Moles MP, Bouabdallah K, Bulabois CE, Dupuis J, Rio B, Gratecos N, Yakoub-Agha I, Attal M, Tournilhac O, Decaudin D, Bourhis JH, Blaise D, Volteau C, Michallet M; Société Française de Greffe de Moëlle et de Thérapie Cellulaire. Le Gouill S, et al. Among authors: de latour rp. J Clin Oncol. 2008 May 10;26(14):2264-71. doi: 10.1200/JCO.2007.14.1366. Epub 2008 Apr 7. J Clin Oncol. 2008. PMID: 18390969
Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial.
Chevallier P, Labopin M, Socié G, Tabrizi R, Furst S, Lioure B, Guillaume T, Delaunay J, de La Tour RP, Vigouroux S, El-Cheikh J, Blaise D, Michallet M, Bilger K, Milpied N, Moreau P, Mohty M. Chevallier P, et al. Haematologica. 2014 Sep;99(9):1486-91. doi: 10.3324/haematol.2014.108563. Epub 2014 Jun 20. Haematologica. 2014. PMID: 24951467 Free PMC article. Clinical Trial.
Equivalent outcomes using reduced intensity or conventional myeloablative conditioning transplantation for patients aged 35 years and over with AML.
Sébert M, Porcher R, Robin M, Adès L, Boissel N, Raffoux E, Xhaard A, Dhedin N, Larghero J, Himberlin C, Delmer A, Fenaux P, Dombret H, Socié G, de Latour RP. Sébert M, et al. Among authors: de latour rp. Bone Marrow Transplant. 2015 Jan;50(1):74-81. doi: 10.1038/bmt.2014.199. Epub 2014 Sep 22. Bone Marrow Transplant. 2015. PMID: 25243624 Clinical Trial.
Fecal calprotectin and α1-antitrypsin dynamics in gastrointestinal GvHD.
O'Meara A, Kapel N, Xhaard A, Sicre de Fontbrune F, Manéné D, Dhedin N, de Latour RP, Socié G, Robin M. O'Meara A, et al. Among authors: de latour rp. Bone Marrow Transplant. 2015 Aug;50(8):1105-9. doi: 10.1038/bmt.2015.109. Epub 2015 May 11. Bone Marrow Transplant. 2015. PMID: 25961766 Clinical Trial.
127 results